Petiq Inc Cl A (PETQ) |
|
33.19 -1.13 (-3.29%)
|
03-03 16:10 |
|
Open: |
34.16 |
Pre. Close: |
34.32 |
|
High:
|
35.766 |
Low:
|
32.77 |
|
Volume:
|
258,952 |
Market Cap:
|
954M |
|
|
|
|
PetIQ, Inc. operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products The company offers its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. As of March 10, 2020, it operated through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
35.833 - 36.013 |
36.013 - 36.162 |
|
Low:
|
33.813 - 33.999 |
33.999 - 34.153 |
|
Close:
|
34.048 - 34.339 |
34.339 - 34.578 |
|
Technical analysis |
as of: 2021-03-03 3:31:50 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 42.98  One year: 45.89 |
| Support: |
Support1: 32.77 Support2: 27.26 |
| Resistance: |
Resistance1: 36.80 Resistance2: 39.29 |
| Pivot: |
35.03 |
| Moving Average: |
MA(5): 34.97 MA(20): 35.04
MA(100): 32.66 MA(250): 30.86  |
| MACD: |
MACD(12,26): -0.17 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 26.10 %D(3): 36.53 |
| RSI: |
RSI(14): 42.53 |
| 52-week: |
High: 39.29 Low: 15.83 Change(%): 13.9 |
| Average Vol(K): |
3-Month: 31133 10-Days: 31183 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.PETQ has closed above bottom band by 7.5%. Bollinger Bands are 11.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 01 Mar 2021
Brokerages Expect PetIQ, Inc. (NASDAQ:PETQ) Will Announce Quarterly Sales of $209.85 Million - MarketBeat
Sat, 27 Feb 2021
PetIQ, Inc.'s (PETQ) CEO Cord Christensen on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
Sat, 27 Feb 2021
Zacks Investment Research Upgrades PetIQ (NASDAQ:PETQ) to "Hold" - MarketBeat
Fri, 26 Feb 2021
Should You Buy PetIQ Inc (PETQ) Stock on Friday? - InvestorsObserver
Thu, 25 Feb 2021
PetIQ, Inc. (PETQ) Q4 2020 Earnings Call Transcript - AlphaStreet
Thu, 25 Feb 2021
PetIQ (PETQ) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
25 |
| Shares Float (M) |
21 |
|
% Held by Insiders
|
1.46 |
|
% Held by Institutions
|
127.17 |
|
Shares Short (K)
|
4,610 |
|
Shares Short P. Month (K)
|
5,110 |
Stock Financials |
|
EPS
|
-3.240 |
|
EPS Est This Year
|
0.740 |
|
EPS Est Next Year
|
0.860 |
|
Book Value (p.s.)
|
10.510 |
|
Profit Margin
|
-10.13 |
|
Operating Margin
|
1.05 |
|
Return on Assets (ttm)
|
0.7 |
|
Return on Equity (ttm)
|
-26.0 |
|
Qtrly Rev. Growth
|
-12.9 |
|
Gross Profit (p.s.)
|
4.692 |
|
Sales Per Share
|
30.454 |
|
EBITDA (p.s.)
|
1.205 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
43 |
|
Levered Free Cash Flow (M)
|
33 |
Stock Valuations |
|
PE Ratio
|
-10.22 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.15 |
|
Price to Sales
|
1.09 |
|
Price to Cash Flow
|
19.36 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
